Shares of Boston Scientific Corporation (BSX) Sees Large Inflow of Net Money Flow

Boston Scientific Corporation (BSX) : The money flow analysis of Boston Scientific Corporation (BSX) indicates a $3.88 million of outflow was on downticks, whereas, the investors on Wednesday gobbled up stocks worth $5.93 million on upticks. The ratio between the upticks and downticks was clearly in favor of the bulls at 1.53 and so was the total money flow at $2.06 million. The bulls lapped up $1.57 million worth of block trades on upticks. The money flow was $1.57 million in block trades, underlining the interest of the bulls in the stock even when the stock was declining.However, the price action shows that the bears had an upper hand in the stock of Boston Scientific Corporation (BSX), pushing it down by -0.19% for the day. The stock slid $0.05 and traded at $23.68 during the day. Nonetheless, the stock is -0.15% over the previous weeks close.

Boston

Shares of Boston Scientific Corporation appreciated by 0.08% during the last five trading days but lost 2.26% on a 4-week basis. Boston Scientific Corporation is up 3.13% in the last 3-month period. Year-to-Date the stock performance stands at 28.8%.

Boston Scientific Corporation (BSX) : 20 analysts are covering Boston Scientific Corporation (BSX) and their average rating on the stock is 1.63, which is read as a Buy. 12 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Boston Scientific Corporation (BSX) also receives 3 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. A total of 5 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Boston Scientific Corporation (NYSE:BSX): The stock opened at $23.73 and touched an intraday high of $23.77 on Wednesday. During the day, the stock corrected to an intraday low of $23.565, however, the bulls stepped in and pushed the price higher to close in the green at $23.75 with a gain of 0.13% for the day. The total traded volume for the day was 6,611,798. The stock had closed at $23.72 in the previous trading session.

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.